#Injective Leads Major Chains on Revenue-to-FDV Injective $INJ currently shows the highest revenue-to-fully-diluted-valuation ratio among major blockchains in 2026 year-to-date data, at 0.95. That puts it ahead of Solana (0.83) and Arbitrum (0.78), and well above #Ethereum $ETH (0.11), #sui , and #Avalanche (both around 0.08). Network revenue feeds monthly $INJ buybacks that permanently remove tokens from circulation. The project expects revenue to grow as new tokenization products and initiatives come online. A high ratio highlights real on-chain activity relative to valuation, but it does not guarantee price gains. Investors are watching whether sustained revenue growth and the buybacks actually translate into lasting token demand.